Published by Iain Gilbert on 24th January 2023
(Sharecast News) - Reneuron revealed on Tuesday that chief financial officer John Hawkins had acquired 100,000 ordinary shares in the AIM-listed stem cell technologies group.
URL: http://www.digitallook.com/dl/news/story/33257129/...